CA2177017C - Shaped materials derived from elongate bone particles and process for making same - Google Patents
Shaped materials derived from elongate bone particles and process for making same Download PDFInfo
- Publication number
- CA2177017C CA2177017C CA002177017A CA2177017A CA2177017C CA 2177017 C CA2177017 C CA 2177017C CA 002177017 A CA002177017 A CA 002177017A CA 2177017 A CA2177017 A CA 2177017A CA 2177017 C CA2177017 C CA 2177017C
- Authority
- CA
- Canada
- Prior art keywords
- bone particles
- bone
- shaped material
- particles
- elongate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3847—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
- A61F2002/2839—Bone plugs or bone graft dowels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
Abstract
Surgically implantable shaped materials e.g., sheets, are fabricated from elongate bone particles, advantageously those that have been demineralized. The materials when applied to a bone repair site enhance or accelerate new bone ingrowth by any of a variety of biological and/or mechanical mechanisms.
Description
~ WO 95/15776 2 1 7 7 0 1 7 PCT/US94/14138 SHAPED MATERIALS DERIVED FROM ELONGATE
1 BONE PARTICLES AND PROCESS FOR MAKTtac: SAME
BACKGROUND OF THE INVENTION
This invention"relates to surgically implanted materials fabricated from bone particles and, more particularly, to such materials which are made up of a coherent mass of elongate bone particles.
The use of demineralized bone powder in the repair of bone defects has been a subject of investigation for some time. Bone powder contains one or more substances, possibly bone morphogenic protein (BMP), which induce bone regeneration at the defect site. See, e.g., Covey et al., "Clinical Induction of Bone Repair with Demineralized Bone Matrix or a Bone Morphogenetic Protein", Orthopaedic Review, Vol. XVII, No. 8, pp. 857-863 (August, 1989). According to Habal et al., "Autologous Corticocancellous Bone Paste for Long Bone Discontinuity Defects: An Experimental Approach", Annals of Plastic Surgery, Vol. 15, No. 2, pp. 138-142 (Aug.
1985), autogenous bone wY,iich has been granulated into a pastelike material and combined with autogenous blood has been used in the repair of long bone defects in dogs.
U.S. Patent No. 5,073,373 discloses a deformable, shape-sustaining osteogenic composition, suitable as a filler for osseous defects, in which particles of demineralized bone are uniformly distributed within a carrier which is a liquid polyhydroxy compound such as glycerol. The vast majority of the demineralized bone particles possess random, irregular geometries with an average median length to median thickness ratio of from about 1:1 to about 3:1.
1 BONE PARTICLES AND PROCESS FOR MAKTtac: SAME
BACKGROUND OF THE INVENTION
This invention"relates to surgically implanted materials fabricated from bone particles and, more particularly, to such materials which are made up of a coherent mass of elongate bone particles.
The use of demineralized bone powder in the repair of bone defects has been a subject of investigation for some time. Bone powder contains one or more substances, possibly bone morphogenic protein (BMP), which induce bone regeneration at the defect site. See, e.g., Covey et al., "Clinical Induction of Bone Repair with Demineralized Bone Matrix or a Bone Morphogenetic Protein", Orthopaedic Review, Vol. XVII, No. 8, pp. 857-863 (August, 1989). According to Habal et al., "Autologous Corticocancellous Bone Paste for Long Bone Discontinuity Defects: An Experimental Approach", Annals of Plastic Surgery, Vol. 15, No. 2, pp. 138-142 (Aug.
1985), autogenous bone wY,iich has been granulated into a pastelike material and combined with autogenous blood has been used in the repair of long bone defects in dogs.
U.S. Patent No. 5,073,373 discloses a deformable, shape-sustaining osteogenic composition, suitable as a filler for osseous defects, in which particles of demineralized bone are uniformly distributed within a carrier which is a liquid polyhydroxy compound such as glycerol. The vast majority of the demineralized bone particles possess random, irregular geometries with an average median length to median thickness ratio of from about 1:1 to about 3:1.
Commonly assigned U.S. Patent No. 5,314,476 and U.S. Patent 5,510,396 disclose a flowable osteogenic composition containing entangled demineralized bone particles of relatively high median length to median thickness ratio. The flowable osteogenic composition can possess a paste-like or putty-like consistency as well as a liquid or runny consistency.
SUMMARY OF THE INVENTION
It is a feature of one embodiment of this invention to provide shaped materials fabricated from elongate bone particles and a process for making such materials.
It is another feature of this invention to provide shaped materials which, in preferred embodiments, are fabricated from combinations of bone particles and one or more additives such as plasticizers, flexibilizing agents, biostatic/biocidal agents, fillers, binders, bonding agents, surface active agents, medically/surgically useful substances, and the like.
In keeping with these and related features of this invention, a shaped material is provided which comprises a shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
In accordance with another embodiment of the present invention there is provided a shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 2a to about 100:1 and a median length to median width ratio of from about 50:1 to about 100:1.
Yet another embodiment of the present invention provides a method of fabricating shaped material from elongate bone particles which comprises: applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ration of from about 50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
A still further embodiment of the present invention provided a method of fabricating shaped material from elongate bone particles which comprises: applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 100:1 and a median length to median width ratio of from about 50:1 to about 100:1.
The foregoing shaped material, e.g., in the form of a sheet, can be formed by applying a liquid slurry of elongate bone particles, e.g., filaments or fibers, to a porous support, draining excess liquid from the bone particles, optionally while applying a compressive force to the particles during and/or after drainage of the excess liquid, to provide a coherent, shaped wetted mass of bone particles and, optionally, drying the wetted mass. The material thus formed is relatively rigid when dry and, upon W0 95/15776 - 217701/ . PCT/US94/14138 1 contact with a biocompatible liquid, e.g., water, saline solution, etc., becomes pliable and flexible.
Application of the foregoing shaped material to the site of a bone defect, e.g., one resulting from injury, infection, malignancy or'developmental malformation, leads to new bone ingrowth by one or more biological mechanisms such as osteogenesis, osteoconduction and/or osteoinduction or by one or more physical mechanisms such as constituting a physical barrier to softtissue ingrowth, providing a support or scaffolding for new bone growth, etc.
The term "osteogenic" as applied to the material of this invention shall therefore be understood as referring to the ability of the material of this invention to participate in the process of new bone growth regardless of the mechanism(s) involved.
The term "coherent" as applied to the mass of elongate bone particles refers to the ability of the bone particles to adhere to each other either mechanically, e.g., by entanglement, or by use of a biocompatible adhesive whether the shaped material containing the bone particles is in the dry or wetted, e.g., hydrated, state.
The term "shaped" as applied to the bone material of this invention shall be understood as referring to a determined or regular form or configuration, in contrast to an indeterminate or vague form or configuration (as in the case of a "lump" or other solid mass of no special form) and is characteristic of such materials as sheets, plates, disks, cones, pins, screws, and the like.
The term "rigid" shall be understood to refer to the relatively stiff, inflexible and somewhat brittle nature WO 95115776 2177017 4 PCTl0S94/14138 .
1 of the shaped materials of this invention while in the dry, i.e., unwetted, state.
The term "flexible" ! shall be understood to refer to the ability of the shaped material to become pliable upon being wetted or hydrated with a suitable biocompatible liquid and thus more readily conformable to a bone repair site.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The elongate bone particles employed in the shaped materials of this invention are generally characterized as having relatively high median length to median thickness ratios, e.g., at least about 50:1 and preferably at least about 100:1 and, similarly, relatively high median length to median width ratios, e.g., at least about 10:1 and preferably at least about 50:1. Such particles can be readily obtained by any one of several methods, e.g., by milling or shaving the surface of an entire bone or relatively large section of bone. Thereafter, the resulting elongate bone particles can be optionally demineralized as discussed herein.
Employing a milling technique, particles ranging in median length from about 2 up to about 200 mm or more (as in the case of the long bones), in median thickness from about 0.05 to about 2mm and in median width from about 1 to about 20mm can be readily obtained. Another procedure for obtaining the elongate bone particles herein, particularly useful for pieces of bone of up to about 100 mm in length, is the Cortical Bone Shredding Mill available from Os Processing Inc., 3303 Carnegie Avenue, Cleveland, Ohio 44115. Use of this bone mill results in the production of I long, thin strips which quickly curl lengthwise to provide tubular-like bone particles.
Depending on the procedure employed for producing the elongate bone particles, one can obtain a mass of bone particles containing at least about 60 weight percent, preferably at least about 70 weight percent and most preferably at least aboui_ 80 weight percent of bone particles possessing a median length of from about 2 to about 200 mm or more and preferably from about 10 to about 100 mm, a medianthickness of from about 0.05 to about 2 mm and preferably from about 0.2 to about 1 mm and a median width of from about 1 mm to about 20 mm and preferably from about 2 to about 5 mm. 'These bone particles can possess a median length to median thickness ratio of at least about 50:1 up to about 500:1 or more and preferably from about 50:1 to about 100:1 and a median length to median width ratio of from about 10:1 to about 200:1 and preferably from about 50:1 to about 100:1.
If desired, the mass of elongate bone particles can be graded into different sizes to reduce or eliminate any less desirable size(s) of particles which may be present. In overall appearance, the elongate bone particles can be described as filaments, fibers, threads, slender or narrow strips, etc. As already noted and depending on the manner in whichthey are produced, these elongate particles may have a tendency to curl to provide tubular-like particles. The bone particles can be obtained from cortical, cancellous and/or corticocancellous bone which may be of autogenous, allogenic and/or xenogeneic origin.
Porcine bone is a particularly advantageous type of WO 95115776 217 7 017 6 PCa/17S94/14138 1 xenogeneic bone tissue which can be used as a source for the elongate demineralized bone particles of this invention.
Following the shaving, milling or other technique whereby they are obtained, the elongate bone particles are optionally subjected to demineralization in order to reduce their inorganic content to a low level, e.g., to not more than about 5% by weight of residual calcium and preferably to not more than about 0.5% by weight residual calcium.
Demineralization of the bone particles will ordinarily 70 result in producing particles of slightly smaller dimensions.
The elongate bone particles can be demineralized in accordance with known and conventional procedures. In a preferred demineralization procedure, the elongate bone particles are subjected to a defatting/ disinfecting step which is followed by an acid demineralization step. A
preferred defatting/disinfectantsolution is an aqueous solution of ethanol, the ethanol being a good solvent for lipids and the water being a good hydrophilic carrier to enable the solution to penetrate more deeply into the bone particles. The aqueous ethanol solution also disinfects the bone by killing vegetative microorganisms and viruses.
Ordinarily at least about 10 to about 40 weight percent by weight of water (i.e., about 60 to about 90 weight percent of defatting agent such as alcohol) should be present in the defatting/disinfecting solution to produce optimal lipid removal and disinfection within the shortest period of time.
The preferred concentration range of the defatting solution is from about 60 to about 85 weight percent alcohol and most preferably about 70 weight percent alcohol. Following defatting, the bone particles are immersed in acid over time i =~ '( I to effect their demineralization. Acids which can be employed in this step include inorganic acids such as hydrochloric acid and organic acids such as peracetic acid.
After acid treatment, the demineralized bone particles are rinsed with sterile water for injection to remove residual amounts of acid and thereby raise the pH. At this point some entanglement of the wet demineralized bone particles will result. The wet demineralized bone particles can then be immediately shaped into a shaped osteogenic material in accordance with the method of this invention or stored under aseptic conditions, advantageously in a lyophilized state, for processing at a later time.
The elongate bone particles can be admixed with one or more substances such as adhesives, fillers, plasticizers, flexibilizing agents, biostatic/biocidal agents, surface active agents, binding and bonding agents, fillers, and the like, prior to; during, or after shaping the particles into a desired configuration. = Suitable adhesives, binding agents and bonding agents include acrylic resins, cellulosics, bioresorbable polymers such as polyglycolide, polylactide, glycolide-lactide copolymer, etc. Suitable fillers include bone powder, demineralized bone powder, hydroxyapatite, etc: Suitable plasticizers and flexibilizing agents include liquid polyhydroxy compounds such as glycerol, monacetin, diacetin, etc. Suitable biostatic/biocidal agents include antibiotics, povidone, sugars, etc. Suitable surrface active agents include the biocompatible nonionic, cationic, anionic and amphoteric surfactants. - --If desired, the bone particles can be modified in one or more ways, e.g., their protein content can be augmented or modified as described in U.S. Patent Nos.
SUMMARY OF THE INVENTION
It is a feature of one embodiment of this invention to provide shaped materials fabricated from elongate bone particles and a process for making such materials.
It is another feature of this invention to provide shaped materials which, in preferred embodiments, are fabricated from combinations of bone particles and one or more additives such as plasticizers, flexibilizing agents, biostatic/biocidal agents, fillers, binders, bonding agents, surface active agents, medically/surgically useful substances, and the like.
In keeping with these and related features of this invention, a shaped material is provided which comprises a shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
In accordance with another embodiment of the present invention there is provided a shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 2a to about 100:1 and a median length to median width ratio of from about 50:1 to about 100:1.
Yet another embodiment of the present invention provides a method of fabricating shaped material from elongate bone particles which comprises: applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ration of from about 50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
A still further embodiment of the present invention provided a method of fabricating shaped material from elongate bone particles which comprises: applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 100:1 and a median length to median width ratio of from about 50:1 to about 100:1.
The foregoing shaped material, e.g., in the form of a sheet, can be formed by applying a liquid slurry of elongate bone particles, e.g., filaments or fibers, to a porous support, draining excess liquid from the bone particles, optionally while applying a compressive force to the particles during and/or after drainage of the excess liquid, to provide a coherent, shaped wetted mass of bone particles and, optionally, drying the wetted mass. The material thus formed is relatively rigid when dry and, upon W0 95/15776 - 217701/ . PCT/US94/14138 1 contact with a biocompatible liquid, e.g., water, saline solution, etc., becomes pliable and flexible.
Application of the foregoing shaped material to the site of a bone defect, e.g., one resulting from injury, infection, malignancy or'developmental malformation, leads to new bone ingrowth by one or more biological mechanisms such as osteogenesis, osteoconduction and/or osteoinduction or by one or more physical mechanisms such as constituting a physical barrier to softtissue ingrowth, providing a support or scaffolding for new bone growth, etc.
The term "osteogenic" as applied to the material of this invention shall therefore be understood as referring to the ability of the material of this invention to participate in the process of new bone growth regardless of the mechanism(s) involved.
The term "coherent" as applied to the mass of elongate bone particles refers to the ability of the bone particles to adhere to each other either mechanically, e.g., by entanglement, or by use of a biocompatible adhesive whether the shaped material containing the bone particles is in the dry or wetted, e.g., hydrated, state.
The term "shaped" as applied to the bone material of this invention shall be understood as referring to a determined or regular form or configuration, in contrast to an indeterminate or vague form or configuration (as in the case of a "lump" or other solid mass of no special form) and is characteristic of such materials as sheets, plates, disks, cones, pins, screws, and the like.
The term "rigid" shall be understood to refer to the relatively stiff, inflexible and somewhat brittle nature WO 95115776 2177017 4 PCTl0S94/14138 .
1 of the shaped materials of this invention while in the dry, i.e., unwetted, state.
The term "flexible" ! shall be understood to refer to the ability of the shaped material to become pliable upon being wetted or hydrated with a suitable biocompatible liquid and thus more readily conformable to a bone repair site.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The elongate bone particles employed in the shaped materials of this invention are generally characterized as having relatively high median length to median thickness ratios, e.g., at least about 50:1 and preferably at least about 100:1 and, similarly, relatively high median length to median width ratios, e.g., at least about 10:1 and preferably at least about 50:1. Such particles can be readily obtained by any one of several methods, e.g., by milling or shaving the surface of an entire bone or relatively large section of bone. Thereafter, the resulting elongate bone particles can be optionally demineralized as discussed herein.
Employing a milling technique, particles ranging in median length from about 2 up to about 200 mm or more (as in the case of the long bones), in median thickness from about 0.05 to about 2mm and in median width from about 1 to about 20mm can be readily obtained. Another procedure for obtaining the elongate bone particles herein, particularly useful for pieces of bone of up to about 100 mm in length, is the Cortical Bone Shredding Mill available from Os Processing Inc., 3303 Carnegie Avenue, Cleveland, Ohio 44115. Use of this bone mill results in the production of I long, thin strips which quickly curl lengthwise to provide tubular-like bone particles.
Depending on the procedure employed for producing the elongate bone particles, one can obtain a mass of bone particles containing at least about 60 weight percent, preferably at least about 70 weight percent and most preferably at least aboui_ 80 weight percent of bone particles possessing a median length of from about 2 to about 200 mm or more and preferably from about 10 to about 100 mm, a medianthickness of from about 0.05 to about 2 mm and preferably from about 0.2 to about 1 mm and a median width of from about 1 mm to about 20 mm and preferably from about 2 to about 5 mm. 'These bone particles can possess a median length to median thickness ratio of at least about 50:1 up to about 500:1 or more and preferably from about 50:1 to about 100:1 and a median length to median width ratio of from about 10:1 to about 200:1 and preferably from about 50:1 to about 100:1.
If desired, the mass of elongate bone particles can be graded into different sizes to reduce or eliminate any less desirable size(s) of particles which may be present. In overall appearance, the elongate bone particles can be described as filaments, fibers, threads, slender or narrow strips, etc. As already noted and depending on the manner in whichthey are produced, these elongate particles may have a tendency to curl to provide tubular-like particles. The bone particles can be obtained from cortical, cancellous and/or corticocancellous bone which may be of autogenous, allogenic and/or xenogeneic origin.
Porcine bone is a particularly advantageous type of WO 95115776 217 7 017 6 PCa/17S94/14138 1 xenogeneic bone tissue which can be used as a source for the elongate demineralized bone particles of this invention.
Following the shaving, milling or other technique whereby they are obtained, the elongate bone particles are optionally subjected to demineralization in order to reduce their inorganic content to a low level, e.g., to not more than about 5% by weight of residual calcium and preferably to not more than about 0.5% by weight residual calcium.
Demineralization of the bone particles will ordinarily 70 result in producing particles of slightly smaller dimensions.
The elongate bone particles can be demineralized in accordance with known and conventional procedures. In a preferred demineralization procedure, the elongate bone particles are subjected to a defatting/ disinfecting step which is followed by an acid demineralization step. A
preferred defatting/disinfectantsolution is an aqueous solution of ethanol, the ethanol being a good solvent for lipids and the water being a good hydrophilic carrier to enable the solution to penetrate more deeply into the bone particles. The aqueous ethanol solution also disinfects the bone by killing vegetative microorganisms and viruses.
Ordinarily at least about 10 to about 40 weight percent by weight of water (i.e., about 60 to about 90 weight percent of defatting agent such as alcohol) should be present in the defatting/disinfecting solution to produce optimal lipid removal and disinfection within the shortest period of time.
The preferred concentration range of the defatting solution is from about 60 to about 85 weight percent alcohol and most preferably about 70 weight percent alcohol. Following defatting, the bone particles are immersed in acid over time i =~ '( I to effect their demineralization. Acids which can be employed in this step include inorganic acids such as hydrochloric acid and organic acids such as peracetic acid.
After acid treatment, the demineralized bone particles are rinsed with sterile water for injection to remove residual amounts of acid and thereby raise the pH. At this point some entanglement of the wet demineralized bone particles will result. The wet demineralized bone particles can then be immediately shaped into a shaped osteogenic material in accordance with the method of this invention or stored under aseptic conditions, advantageously in a lyophilized state, for processing at a later time.
The elongate bone particles can be admixed with one or more substances such as adhesives, fillers, plasticizers, flexibilizing agents, biostatic/biocidal agents, surface active agents, binding and bonding agents, fillers, and the like, prior to; during, or after shaping the particles into a desired configuration. = Suitable adhesives, binding agents and bonding agents include acrylic resins, cellulosics, bioresorbable polymers such as polyglycolide, polylactide, glycolide-lactide copolymer, etc. Suitable fillers include bone powder, demineralized bone powder, hydroxyapatite, etc: Suitable plasticizers and flexibilizing agents include liquid polyhydroxy compounds such as glycerol, monacetin, diacetin, etc. Suitable biostatic/biocidal agents include antibiotics, povidone, sugars, etc. Suitable surrface active agents include the biocompatible nonionic, cationic, anionic and amphoteric surfactants. - --If desired, the bone particles can be modified in one or more ways, e.g., their protein content can be augmented or modified as described in U.S. Patent Nos.
4,743,259 and 4,902,296. Any of a variety of medically and/or surgically useful substances can be incorporated in, or associated with, the bone particles either before, during or after fabrication of the shaped articles disclosed herein. Thus, e.g., one or more of such substances can be introduced into the demineralized bone particles, e.g., by soaking or immersing the bone particles in a solution or dispersion of the desired substance(s).
Medically/surgically useful substances which can be readily combined with the demineralized bone particles and/or osteogenic material of this invention include, e.g., collagen, insoluble collagen and derivatives, etc., and soluble solids and/or liquids dissolved therein, e.g., antiviricides, particularly those effective against HIV and hepatitis; antimicrobials and/or antibiotics such as erythromycin, bacitracin, neomycin, penicillin, polymyxin B, tetracyclines, viomycin, chloromycetin and streptomycins, cefazolin, ampicillin, azactam, tobramycin, clindamycin and gentamicin, etc.; biocidal/biostatic sugars such as dextroal, glucose, etc.; amino acids, peptides, vitamins, inorganic elements, co-factors for protein synthesis;
hormones, endocrime tissue or tissue fragments;
synthesizers; enzymes such as collagenase, peptidases, oxidases, etc.; polymer cell scaffolds with parnechymal cells; angiogenic drugs and polymeric carriers containing such drugs; collagen lattices; antigenic agents;
cytoskeletal agents; cartilage fragments, living cells such as chondrocytes, bone marrow cells, mesenchymal stem cells, natural extracts, tissue transplants, bone, demineralized bone powder, autogenous tissues such as blood, serum, soft tissue, bone marrow, etc.; bioadhesives, bone morphogenic proteins (BMPs), transforming growth factor (TGF-beta), insulin-like growth factor (IGF-1); growth hormones such as somatotropin; bone digestors; antitumor agents; immuno-suppressants; permeation enhancers, e.g., fatty acid esters such as laureate, myristate and stearate monoesters of polyethylene glycol, enamine derivatives, alpha-keto aldehydes, etc.; cellular attractants; fibronectins;
cellular attachment agents; and nucleic acids. The amounts of such optionally added substances can vary widely with optimum levels being readily determined in a specific case by routine experimentation.
To prepare the shaped osteogenic materials of this invention, a quantity of elongate bone particles, preferably those that have been demineralized, slurried in a suitable liquid, e.g., water, organic protic solvent, aqueous solution such a physiological saline, etc., and optionally containing one or more biocompatible ingredients such as adhesives, fillers, plasticizers, flexibilizing agents, biostatic/biocidal agents, surface active agents, medically/surgically useful substances, etc., as previously described is applied to a form such as a flat sheet, mesh screen or three-dimensional mold and excess liquid is removed, e.g., by being drained away. This procedure is referred to herein as "wet-laying". For example, in the case of a sheet, the thickness of the layer of wetted bone particles can vary widely, e.g., from about 1 to about 40 mm. Some particle entanglement results from the wet-laying operation. Further particle entanglement, if necessary or desirable, can be effected by the use of water jets or other suitable mechanical entangling methods. Either before or after the wet-laying procedure, one or more additional ~ substances can be added to the bone particles, e.g., thixotropic agents, therapeutic agents, and the like, as previously mentioned. The wet demineralized bone particles are then dried either in an oven at a temperature of from about 300 to about 70 C, preferably from about 300 to about 40 C, or by lyophilization in accordance with procedures and conditions that are well known in the art, e.g., a shelf temperature of from about -20 to about -35 C, a vacuum of from about 150 to about 100 mTorr for a time of from about 4 to about 48 hours depending on the mass. In an alternative embodiment herein, the entangled mass of bone particles can be subjected to a compressive force, e:g., of up to about 100 psi, during and/or after-the wet-laying step and/or while the drained but still wet shaped article is being dried. The resulting shaped material is rigid and relatively strong when dry and flexible and pliable when wetted or hydrated.
At the site of implantation, the shaped article can be employed in the dry state or, where site conformation is desired, in the hydrated state. The dry or hydrated article can be cut or sized if need be to conform to a site being repaired. The article can be hydrated with a suitable biocompatible liquid, e.g., water, saline solution, etc., for a period of time ranging from about 1 to about 120 minutes depending on the density of the shaped material.
After being hydrated, the shaped material becomes flexible yet retains its shape and much of its strength. The shaped material of this invention can be packaged in either the dried or wet state and stored for subsequent application.
In some circumstances, it is preferable to package the 217,701;7 material in the wet state so that it is ready for immediate use at the surgical site.
The shaped materials of this invention can be utilized in a wide variety of orthopaedic, neurosurgical and oral and maxillofacial surgical procedures such as the repair of simple and compound fractures and non-unions, external and internal fixations, joint reconstructions such as arthrodesis, general arthroplasty, cup arthroplasty of the hip, femoral and humeral head replacement,-femoral head surface replacement and total joint replacement, repairs of the vertebral column including spinal fusion and internal fixation, tumor surgery, e.g. deficit filling, discectomy, laminectomy, excision of spinal cord tumors, anterior cervical and thoracic operations, repair of spinal injuries, scoliosis, lordosis and kyphosis treatments, intermaxillary fixation of fractures, mentoplasty, temporomandibular joint replacement, alveolar ridge augmentation and reconstruction, inlay bone grafts, implant placement and revision, sinus lifts, etc. These materials can be sutured or stapled in place for anchoring purposes and serve in guided tissue regeneration or as barrier materials.
The following examples are illustrative of the preparation of composition containing elongate demineralized bone particles and the fabrication of a shaped sheet material from the composition.
A section of allogenic cortical bone approximately 9 cm long and 10-30 mm wide was placed in the hopper of a Cortical Bone Shredding Mill of Os Processing, Inc., 3303 Carnegie Avenue, Cleveland, Ohio 44115 equipped with a 20-flute rotary cutter.- The mill was operated at a speed of about 120 rpm until approximately 100 to 1000 g of mass of bone particles of which at least 80 weight percent was made up of particles having a median length of about 10 mm and a median thickness of about 0.5 mm was obtained. The elongate bone particles were then placed in a reactor. A 70 weight percent ethanol solution at a rate-of 30 milliliters per gram of bone particles was introduced into the reactor .
followed by agitation for 1 hour (Bolander et al., Journal of Bone and Joint Suraerv, Vol. 68-A, No. 8 (Oct. 1986)) to effect defatting arid disinfecting of the bone particles.
Following drainage of the ethanol, a 0.6N solution of HC1 at ml per gram of bone was introduced into the reactor (Bolander et al., supra), the reaction proceeding for 3 15 hours (Glowackie, AATB Workshoo, llth Annual meeting (1987).
Following drainage of the HC1, the bone particles were covered and rinsed three times with water for injection (WFI) with the WFI being replaced at 5 minute intervals.
Following drainage of the WFI, the bone particles were completely covered with 0.1M sodium phosphate, a procedure which was repeated until the pH of the solution fell between 6.8 and 7.4. The rinsing procedure with WFI was repeated to provide a composition containing wet demineralized, elongate bone particles containing not more than about 0.5 weight percent residual calcium.
A quantity of the composition containing wet demineralized bone particles from Example 1 was spread out on a tight-mesh screen to a depth of 10mm to form a flat sheet with dimensions of 5 inches by 5 inches while excess WO 95/15776 2~77~~7 PCT/US94/14138 I liquid drained off through the screen. The entire surface was subjected to about 8psi and the load was maintained while the sheet was oven-dried. The resultant rigid sheet was approximately 5 mm in depth, brittle to some extent, and had significant tensile strength. A 2 inch by 2 inch = portion of the sheet was cut off with scissors and immersed in water for injection for 15 minutes. The sheet approximately doubled in thickness after this time. The piece was now significantly more pliable and could be bent in a circular fashion so that the opposite sides met. The integrity of the structure was not visibly affected by this bending and the piece returned to its original shape upon release. A sheet material which is more pliable or less pliable can be accomplislzed by changing the initial thickness of the particli=_s during the wet-lay process or by varying the compression force.
' EXAMPLE 3 The hydrated sheet of Example 2 is applied to an osseous defect site using an instrument such as forceps.
The ability of the foregoing shaped material to maintain its shape and position in the aqueous environment of the body is superior to a like quantity of demineralized bone powder.
=
Medically/surgically useful substances which can be readily combined with the demineralized bone particles and/or osteogenic material of this invention include, e.g., collagen, insoluble collagen and derivatives, etc., and soluble solids and/or liquids dissolved therein, e.g., antiviricides, particularly those effective against HIV and hepatitis; antimicrobials and/or antibiotics such as erythromycin, bacitracin, neomycin, penicillin, polymyxin B, tetracyclines, viomycin, chloromycetin and streptomycins, cefazolin, ampicillin, azactam, tobramycin, clindamycin and gentamicin, etc.; biocidal/biostatic sugars such as dextroal, glucose, etc.; amino acids, peptides, vitamins, inorganic elements, co-factors for protein synthesis;
hormones, endocrime tissue or tissue fragments;
synthesizers; enzymes such as collagenase, peptidases, oxidases, etc.; polymer cell scaffolds with parnechymal cells; angiogenic drugs and polymeric carriers containing such drugs; collagen lattices; antigenic agents;
cytoskeletal agents; cartilage fragments, living cells such as chondrocytes, bone marrow cells, mesenchymal stem cells, natural extracts, tissue transplants, bone, demineralized bone powder, autogenous tissues such as blood, serum, soft tissue, bone marrow, etc.; bioadhesives, bone morphogenic proteins (BMPs), transforming growth factor (TGF-beta), insulin-like growth factor (IGF-1); growth hormones such as somatotropin; bone digestors; antitumor agents; immuno-suppressants; permeation enhancers, e.g., fatty acid esters such as laureate, myristate and stearate monoesters of polyethylene glycol, enamine derivatives, alpha-keto aldehydes, etc.; cellular attractants; fibronectins;
cellular attachment agents; and nucleic acids. The amounts of such optionally added substances can vary widely with optimum levels being readily determined in a specific case by routine experimentation.
To prepare the shaped osteogenic materials of this invention, a quantity of elongate bone particles, preferably those that have been demineralized, slurried in a suitable liquid, e.g., water, organic protic solvent, aqueous solution such a physiological saline, etc., and optionally containing one or more biocompatible ingredients such as adhesives, fillers, plasticizers, flexibilizing agents, biostatic/biocidal agents, surface active agents, medically/surgically useful substances, etc., as previously described is applied to a form such as a flat sheet, mesh screen or three-dimensional mold and excess liquid is removed, e.g., by being drained away. This procedure is referred to herein as "wet-laying". For example, in the case of a sheet, the thickness of the layer of wetted bone particles can vary widely, e.g., from about 1 to about 40 mm. Some particle entanglement results from the wet-laying operation. Further particle entanglement, if necessary or desirable, can be effected by the use of water jets or other suitable mechanical entangling methods. Either before or after the wet-laying procedure, one or more additional ~ substances can be added to the bone particles, e.g., thixotropic agents, therapeutic agents, and the like, as previously mentioned. The wet demineralized bone particles are then dried either in an oven at a temperature of from about 300 to about 70 C, preferably from about 300 to about 40 C, or by lyophilization in accordance with procedures and conditions that are well known in the art, e.g., a shelf temperature of from about -20 to about -35 C, a vacuum of from about 150 to about 100 mTorr for a time of from about 4 to about 48 hours depending on the mass. In an alternative embodiment herein, the entangled mass of bone particles can be subjected to a compressive force, e:g., of up to about 100 psi, during and/or after-the wet-laying step and/or while the drained but still wet shaped article is being dried. The resulting shaped material is rigid and relatively strong when dry and flexible and pliable when wetted or hydrated.
At the site of implantation, the shaped article can be employed in the dry state or, where site conformation is desired, in the hydrated state. The dry or hydrated article can be cut or sized if need be to conform to a site being repaired. The article can be hydrated with a suitable biocompatible liquid, e.g., water, saline solution, etc., for a period of time ranging from about 1 to about 120 minutes depending on the density of the shaped material.
After being hydrated, the shaped material becomes flexible yet retains its shape and much of its strength. The shaped material of this invention can be packaged in either the dried or wet state and stored for subsequent application.
In some circumstances, it is preferable to package the 217,701;7 material in the wet state so that it is ready for immediate use at the surgical site.
The shaped materials of this invention can be utilized in a wide variety of orthopaedic, neurosurgical and oral and maxillofacial surgical procedures such as the repair of simple and compound fractures and non-unions, external and internal fixations, joint reconstructions such as arthrodesis, general arthroplasty, cup arthroplasty of the hip, femoral and humeral head replacement,-femoral head surface replacement and total joint replacement, repairs of the vertebral column including spinal fusion and internal fixation, tumor surgery, e.g. deficit filling, discectomy, laminectomy, excision of spinal cord tumors, anterior cervical and thoracic operations, repair of spinal injuries, scoliosis, lordosis and kyphosis treatments, intermaxillary fixation of fractures, mentoplasty, temporomandibular joint replacement, alveolar ridge augmentation and reconstruction, inlay bone grafts, implant placement and revision, sinus lifts, etc. These materials can be sutured or stapled in place for anchoring purposes and serve in guided tissue regeneration or as barrier materials.
The following examples are illustrative of the preparation of composition containing elongate demineralized bone particles and the fabrication of a shaped sheet material from the composition.
A section of allogenic cortical bone approximately 9 cm long and 10-30 mm wide was placed in the hopper of a Cortical Bone Shredding Mill of Os Processing, Inc., 3303 Carnegie Avenue, Cleveland, Ohio 44115 equipped with a 20-flute rotary cutter.- The mill was operated at a speed of about 120 rpm until approximately 100 to 1000 g of mass of bone particles of which at least 80 weight percent was made up of particles having a median length of about 10 mm and a median thickness of about 0.5 mm was obtained. The elongate bone particles were then placed in a reactor. A 70 weight percent ethanol solution at a rate-of 30 milliliters per gram of bone particles was introduced into the reactor .
followed by agitation for 1 hour (Bolander et al., Journal of Bone and Joint Suraerv, Vol. 68-A, No. 8 (Oct. 1986)) to effect defatting arid disinfecting of the bone particles.
Following drainage of the ethanol, a 0.6N solution of HC1 at ml per gram of bone was introduced into the reactor (Bolander et al., supra), the reaction proceeding for 3 15 hours (Glowackie, AATB Workshoo, llth Annual meeting (1987).
Following drainage of the HC1, the bone particles were covered and rinsed three times with water for injection (WFI) with the WFI being replaced at 5 minute intervals.
Following drainage of the WFI, the bone particles were completely covered with 0.1M sodium phosphate, a procedure which was repeated until the pH of the solution fell between 6.8 and 7.4. The rinsing procedure with WFI was repeated to provide a composition containing wet demineralized, elongate bone particles containing not more than about 0.5 weight percent residual calcium.
A quantity of the composition containing wet demineralized bone particles from Example 1 was spread out on a tight-mesh screen to a depth of 10mm to form a flat sheet with dimensions of 5 inches by 5 inches while excess WO 95/15776 2~77~~7 PCT/US94/14138 I liquid drained off through the screen. The entire surface was subjected to about 8psi and the load was maintained while the sheet was oven-dried. The resultant rigid sheet was approximately 5 mm in depth, brittle to some extent, and had significant tensile strength. A 2 inch by 2 inch = portion of the sheet was cut off with scissors and immersed in water for injection for 15 minutes. The sheet approximately doubled in thickness after this time. The piece was now significantly more pliable and could be bent in a circular fashion so that the opposite sides met. The integrity of the structure was not visibly affected by this bending and the piece returned to its original shape upon release. A sheet material which is more pliable or less pliable can be accomplislzed by changing the initial thickness of the particli=_s during the wet-lay process or by varying the compression force.
' EXAMPLE 3 The hydrated sheet of Example 2 is applied to an osseous defect site using an instrument such as forceps.
The ability of the foregoing shaped material to maintain its shape and position in the aqueous environment of the body is superior to a like quantity of demineralized bone powder.
=
Claims (34)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
2. The shaped material of claim 1 exhibiting osteogenic activity.
3. The shaped material of claim 1, wherein the bone particles are obtained from cortical, cancellous or corticocancellous bone of autogenous, allogenic or xenogeneic origin.
4. The shaped material of claim 1, wherein the bone particles are obtained from porcine bone.
5. The shaped material of any one of claim 1 to 4 further comprising one or more additives selected from the group consisting of plasticizers, flexibilizing agents, biostatic agents, biocidal agents, surface active agents, binding and bonding agents and fillers.
6. The shaped material of any one of claims 1 to 4 further comprising at least one additional ingredient selected from the group consisting of antiviral agent, antimicrobial agent antibiotic agent, amino acid, peptide, vitamin, inorganic element, protein synthesis co-factor, hormone, endocrine tissue, synthesizer, enzyme, polymer-cell scaffolding agent with parenchymal cells, angiogenic drug, demineralized bone powder, collagen lattice, antigenic agent, cytoskeletal agent, mesenchymal stem cells, bone digester, antitumor agent, cellular attractant, fibronectin, growth hormone, cellular attachment agent, immuno-suppressant, nucleic acid, hydroxy apatite and penetration enhancer.
7. The shaped material of any one of claims 1 to 6 in the form of a flat sheet, curved sheet, plate, disk, cone, pin, screw or tube.
8. The shaped material of any one of claims 1 to 7, wherein the elongate bone particles curl.
9. A shaped material comprising a coherent mass of elongate, mechanically entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 100:1 and a median length to median width ratio of from about 50:1 to about 100:1.
10. The shaped material of claim 9 exhibiting osteogenic activity.
11. The shaped material of claim 9, wherein the bone particles are obtained from cortical, cancellous or corticocancellous bone of autogenous, allogenic or xenogeneic origin.
12. The shaped material of claim 9, wherein the bone particles are obtained from porcine bone.
13. The shaped material of any one of claims 9 to 12 further comprising one or more additives selected from the group consisting of plasticizers, flexibilizing agents, biostatic agents, biocidal agents, surface active agents, binding and bonding agents and fillers.
14. The shaped material of any one of claims 9 to 12, further comprising at least one additional ingredient selected from the group consisting of antiviral agent, antimicrobial agent, antibiotic agent, amino acid, peptide, vitamin, inorganic element, protein synthesis co-factor, hormone, endocrine tissue, synthesizer, enzyme, polymer-cell scaffolding agent with parenchymal cells, angiogenic drug, demineralized bone powder, collagen lattice, antigenic agent, cytoskeletal agent, mesenchymal stem cells, bone digester, antitumor agent, cellular attractant, fibronectin, growth hormone, cellular attachment agent, immuno-suppressant, nucleic acid, hydroxy apatite and penetration enhancer.
15. The shaped material of any one of claims 9 to 14 in the form of a flat sheet, curved sheet, plate, disk, cone, pin screw or tube.
16. The shaped material of any one of claims 9 to 15, wherein the elongate bone particles each curl.
17. A method of fabricating shaped material from elongate bone particles which comprises:
applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ration of from about.50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ration of from about.50:1 to about 500:1 and a median length to median width ratio of from about 10:1 to about 200:1.
18. The method of claim 17 further comprising the step of compressing the demineralized bone particles during and/or after drainage of the excess liquid.
19. The method of claim 17 further comprising the step of drying the demineralized bone particles after drainage of the excess liquid.
20. The method of claim 18 further comprising the step of drying the demineralized bone particles during and/or after compression of the particles.
21. The method of claim 18, wherein the demineralized bone particles are compressed under a force ranging from about 3,447 to about 689,475.728 newton per square meter of surface area.
22. The method of any one of claims 17 to 21, wherein the shaped material exhibits osteogenic activity.
23. The method of any one of claims 17 to 21, wherein the bone particles are obtained from cortical, cancellous or corticocancellous bone of autogenous, allogenic or xenogeneic origin.
24. The method of any one of claims 17 to 21, wherein the bone particles are obtained from porcine bone.
25. The method of any one of claims 17 to 24 comprising the additional step of preparing the individual elongate bone particles in the shape of strips that curl.
26. A method of fabricating shaped material from elongate bone particles which comprises:
applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 100:1 and a median length to median width'ratio of from about 50:1 to about 100:1.
applying a liquid slurry of elongate bone particles to a porous support; and draining excess liquid from the bone particles to provide a coherent shaped wetted mass of elongate, mechanically-entangled, demineralized bone particles wherein at least about 60 weight percent of the bone particles possess a median length to median thickness ratio of from about 50:1 to about 100:1 and a median length to median width'ratio of from about 50:1 to about 100:1.
27. The method of claim 26 further comprising the step of compressing the demineralized bone particles during and/or after drainage of the excess liquid.
28. The method of claim 26 further comprising the step of drying the demineralized bone particles after drainage of the excess liquid.
29. The method of claim 27 further comprising the step of drying the demineralized bone particles during and/or after compression of the particles.
30. The method of claim 27, wherein the demineralized bone particles are compressed under a force ranging from about 3,447 to about 689,475.728 newton per square meter of surface area.
31. The method of any one of claims 26 to 30, wherein the shaped material exhibits osteogenic activity.
32. The method of any one of claims 26 to 31, wherein the bone particles are obtained from cortical, cancellous or corticocancellous bone of autogenous, allogenic or xenogeneic origin.
33. The method of any one of claims 26 to 31, wherein the bone particles are obtained from porcine bone.
34. The method of any one of claims 26 to 33 comprising the additional step of preparing the individual elongate bone particles in the shape of strips that curl.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/164,152 | 1993-12-09 | ||
US08/164,152 US5507813A (en) | 1993-12-09 | 1993-12-09 | Shaped materials derived from elongate bone particles |
PCT/US1994/014138 WO1995015776A1 (en) | 1993-12-09 | 1994-12-08 | Shaped materials derived from elongate bone particles and process for making same |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2177017A1 CA2177017A1 (en) | 1995-06-15 |
CA2177017C true CA2177017C (en) | 2008-04-15 |
Family
ID=22593208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002177017A Expired - Lifetime CA2177017C (en) | 1993-12-09 | 1994-12-08 | Shaped materials derived from elongate bone particles and process for making same |
Country Status (8)
Country | Link |
---|---|
US (1) | US5507813A (en) |
EP (1) | EP0732947B1 (en) |
JP (1) | JP3471359B2 (en) |
AT (1) | ATE213958T1 (en) |
CA (1) | CA2177017C (en) |
DE (1) | DE69430069T2 (en) |
ES (1) | ES2173946T3 (en) |
WO (1) | WO1995015776A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
Families Citing this family (283)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10508504A (en) * | 1994-09-16 | 1998-08-25 | バイオプシス メディカル インコーポレイテッド | Method and apparatus for identifying and marking tissue |
US5697932A (en) | 1994-11-09 | 1997-12-16 | Osteonics Corp. | Bone graft delivery system and method |
US6206922B1 (en) | 1995-03-27 | 2001-03-27 | Sdgi Holdings, Inc. | Methods and instruments for interbody fusion |
US5782919A (en) * | 1995-03-27 | 1998-07-21 | Sdgi Holdings, Inc. | Interbody fusion device and method for restoration of normal spinal anatomy |
EP0880345B1 (en) * | 1996-01-17 | 2006-04-05 | Osteotech, Inc. | Process for producing flexible sheets from demineralized, elongate, bone particles |
US6652260B2 (en) | 1996-03-11 | 2003-11-25 | The Board Of Trustees Of The University Of Arkansas | Composite allograft press |
US5824078A (en) * | 1996-03-11 | 1998-10-20 | The Board Of Trustees Of The University Of Arkansas | Composite allograft, press, and methods |
US5868749A (en) * | 1996-04-05 | 1999-02-09 | Reed; Thomas M. | Fixation devices |
US5676146B1 (en) * | 1996-09-13 | 2000-04-18 | Osteotech Inc | Surgical implant containing a resorbable radiopaque marker and method of locating such within a body |
US6165487A (en) * | 1996-09-30 | 2000-12-26 | Children's Medical Center Corporation | Methods and compositions for programming an organic matrix for remodeling into a target tissue |
WO1998014222A1 (en) * | 1996-09-30 | 1998-04-09 | Children's Medical Center Corporation | Methods and compositions for programming an organic matrix for remodeling into a target tissue |
US20010031254A1 (en) * | 1998-11-13 | 2001-10-18 | Bianchi John R. | Assembled implant |
US6482584B1 (en) | 1998-11-13 | 2002-11-19 | Regeneration Technologies, Inc. | Cyclic implant perfusion cleaning and passivation process |
US6309420B1 (en) * | 1997-10-14 | 2001-10-30 | Parallax Medical, Inc. | Enhanced visibility materials for implantation in hard tissue |
US6090998A (en) * | 1997-10-27 | 2000-07-18 | University Of Florida | Segmentally demineralized bone implant |
US6652592B1 (en) | 1997-10-27 | 2003-11-25 | Regeneration Technologies, Inc. | Segmentally demineralized bone implant |
US6270464B1 (en) * | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US5899939A (en) * | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US6986788B2 (en) * | 1998-01-30 | 2006-01-17 | Synthes (U.S.A.) | Intervertebral allograft spacer |
US6290718B1 (en) | 1998-02-02 | 2001-09-18 | Regeneration Technologies, Inc. | Luminal graft, stent or conduit made of cortical bone |
US6123731A (en) | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US20040081704A1 (en) | 1998-02-13 | 2004-04-29 | Centerpulse Biologics Inc. | Implantable putty material |
US6437018B1 (en) | 1998-02-27 | 2002-08-20 | Musculoskeletal Transplant Foundation | Malleable paste with high molecular weight buffered carrier for filling bone defects |
US6911212B2 (en) | 1998-02-27 | 2005-06-28 | Musculoskeletal Transplant Foundation | Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects |
US6326018B1 (en) | 1998-02-27 | 2001-12-04 | Musculoskeletal Transplant Foundation | Flexible sheet of demineralized bone |
US7019192B2 (en) * | 1998-02-27 | 2006-03-28 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
US6458375B1 (en) | 1998-02-27 | 2002-10-01 | Musculoskeletal Transplant Foundation | Malleable paste with allograft bone reinforcement for filling bone defects |
US7045141B2 (en) | 1998-02-27 | 2006-05-16 | Musculoskeletal Transplant Foundation | Allograft bone composition having a gelatin binder |
USRE38522E1 (en) * | 1998-02-27 | 2004-05-25 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
US6030635A (en) * | 1998-02-27 | 2000-02-29 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
US6998135B1 (en) | 1998-02-27 | 2006-02-14 | Musculoskeletal Transplant Foundation | Demineralized corticocancellous bone sheet |
WO1999049819A1 (en) | 1998-04-01 | 1999-10-07 | Parallax Medical, Inc. | Pressure applicator for hard tissue implant placement |
US7572263B2 (en) * | 1998-04-01 | 2009-08-11 | Arthrocare Corporation | High pressure applicator |
US20020058882A1 (en) * | 1998-06-22 | 2002-05-16 | Artemis Medical, Incorporated | Biopsy localization method and device |
US20030217415A1 (en) * | 1998-06-30 | 2003-11-27 | Katrina Crouch | Plasticized bone grafts and methods of making and using same |
US20100030340A1 (en) * | 1998-06-30 | 2010-02-04 | Wolfinbarger Jr Lloyd | Plasticized Grafts and Methods of Making and Using Same |
US7063726B2 (en) * | 1998-06-30 | 2006-06-20 | Lifenet | Plasticized bone grafts and methods of making and using same |
US8563232B2 (en) * | 2000-09-12 | 2013-10-22 | Lifenet Health | Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced |
US6293970B1 (en) * | 1998-06-30 | 2001-09-25 | Lifenet | Plasticized bone and soft tissue grafts and methods of making and using same |
US6214054B1 (en) * | 1998-09-21 | 2001-04-10 | Edwards Lifesciences Corporation | Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby |
US6497726B1 (en) | 2000-01-11 | 2002-12-24 | Regeneration Technologies, Inc. | Materials and methods for improved bone tendon bone transplantation |
US8177762B2 (en) * | 1998-12-07 | 2012-05-15 | C. R. Bard, Inc. | Septum including at least one identifiable feature, access ports including same, and related methods |
ES2224737T3 (en) * | 1998-12-14 | 2005-03-01 | Osteotech, Inc., | BONE GRAFT MADE OF OSE PARTICLES. |
US9669113B1 (en) | 1998-12-24 | 2017-06-06 | Devicor Medical Products, Inc. | Device and method for safe location and marking of a biopsy cavity |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6206923B1 (en) * | 1999-01-08 | 2001-03-27 | Sdgi Holdings, Inc. | Flexible implant using partially demineralized bone |
US6547823B2 (en) * | 1999-01-22 | 2003-04-15 | Osteotech, Inc. | Intervertebral implant |
ATE296643T1 (en) * | 1999-02-04 | 2005-06-15 | Sdgi Holdings Inc | OSTEOGENIC PASTE COMPOSITIONS AND THEIR USE |
US8133421B2 (en) * | 1999-02-23 | 2012-03-13 | Warsaw Orthopedic, Inc. | Methods of making shaped load-bearing osteoimplant |
US20070233272A1 (en) * | 1999-02-23 | 2007-10-04 | Boyce Todd M | Shaped load-bearing osteoimplant and methods of making same |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6113638A (en) * | 1999-02-26 | 2000-09-05 | Williams; Lytton A. | Method and apparatus for intervertebral implant anchorage |
US6241770B1 (en) * | 1999-03-05 | 2001-06-05 | Gary K. Michelson | Interbody spinal fusion implant having an anatomically conformed trailing end |
WO2000056254A1 (en) | 1999-03-24 | 2000-09-28 | Parallax Medical, Inc. | Non-compliant system for delivery of implant material |
AU4067800A (en) * | 1999-04-02 | 2000-10-23 | Osteotech, Inc. | Surgical bone screw |
EP1198208B1 (en) * | 1999-05-05 | 2013-07-10 | Warsaw Orthopedic, Inc. | Nested interbody spinal fusion implants |
US7371408B1 (en) * | 1999-06-07 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7435260B2 (en) * | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
DE19944681A1 (en) * | 1999-08-20 | 2001-03-01 | Metz Stavenhagen Peter | Implantable bone substitute material, comprises osteocytes multiplied rapidly using growth factor, especially used by injection into hollow vertebral support |
US6162258A (en) | 1999-08-25 | 2000-12-19 | Osteotech, Inc. | Lyophilized monolithic bone implant and method for treating bone |
US6783515B1 (en) | 1999-09-30 | 2004-08-31 | Arthrocare Corporation | High pressure delivery system |
US20030228288A1 (en) * | 1999-10-15 | 2003-12-11 | Scarborough Nelson L. | Volume maintaining osteoinductive/osteoconductive compositions |
AU2624801A (en) * | 1999-12-30 | 2001-07-16 | Osteotech, Inc. | Intervertebral implants |
US6379385B1 (en) | 2000-01-06 | 2002-04-30 | Tutogen Medical Gmbh | Implant of bone matter |
US20030023304A1 (en) * | 2000-01-11 | 2003-01-30 | Carter Kevin C. | Materials and methods for improved bone tendon bone transplantation |
US20030097179A1 (en) * | 2000-01-11 | 2003-05-22 | Carter Kevin C. | Materials and methods for improved bone tendon bone transplantation |
US7635390B1 (en) | 2000-01-14 | 2009-12-22 | Marctec, Llc | Joint replacement component having a modular articulating surface |
US6814756B1 (en) * | 2000-02-04 | 2004-11-09 | Gary K. Michelson | Expandable threaded arcuate interbody spinal fusion implant with lordotic configuration during insertion |
EP1645248B8 (en) * | 2000-02-04 | 2010-06-16 | Warsaw Orthopedic, Inc. | Expandable interbody spinal fusion implant having pivotally attached blocker |
US6716247B2 (en) | 2000-02-04 | 2004-04-06 | Gary K. Michelson | Expandable push-in interbody spinal fusion implant |
US6709458B2 (en) * | 2000-02-04 | 2004-03-23 | Gary Karlin Michelson | Expandable push-in arcuate interbody spinal fusion implant with tapered configuration during insertion |
US6500205B1 (en) * | 2000-04-19 | 2002-12-31 | Gary K. Michelson | Expandable threaded arcuate interbody spinal fusion implant with cylindrical configuration during insertion |
AU2001288840B2 (en) * | 2000-02-10 | 2008-02-21 | Rti Biologics, Inc. | Assembled implant, including mixed-composition segment |
WO2001078798A1 (en) * | 2000-02-10 | 2001-10-25 | Regeneration Technologies, Inc. | Assembled implant |
AR027685A1 (en) | 2000-03-22 | 2003-04-09 | Synthes Ag | METHOD AND METHOD FOR CARRYING OUT |
US6350283B1 (en) * | 2000-04-19 | 2002-02-26 | Gary K. Michelson | Bone hemi-lumbar interbody spinal implant having an asymmetrical leading end and method of installation thereof |
US7462195B1 (en) | 2000-04-19 | 2008-12-09 | Warsaw Orthopedic, Inc. | Artificial lumbar interbody spinal implant having an asymmetrical leading end |
AU2001255530A1 (en) * | 2000-04-20 | 2001-11-07 | Regeneration Technologies, Inc. | Cortical bone interference screw |
DE10026306A1 (en) * | 2000-05-26 | 2001-11-29 | Tutogen Medical Gmbh | Jawbone transplant is domed and can be bent to U-shapes and is made of spongiose, cortical or compact bone material of human or animal origin |
US6332779B1 (en) | 2000-07-03 | 2001-12-25 | Osteotech, Inc. | Method of hard tissue repair |
EP1296726B1 (en) * | 2000-07-03 | 2004-02-04 | Osteotech, Inc. | Osteogenic implants derived from bone |
US6863694B1 (en) | 2000-07-03 | 2005-03-08 | Osteotech, Inc. | Osteogenic implants derived from bone |
US6808537B2 (en) * | 2000-07-07 | 2004-10-26 | Gary Karlin Michelson | Expandable implant with interlocking walls |
US7001551B2 (en) * | 2000-07-13 | 2006-02-21 | Allograft Research Technologies, Inc. | Method of forming a composite bone material implant |
AU2001275999B2 (en) * | 2000-07-19 | 2007-03-29 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US9387094B2 (en) * | 2000-07-19 | 2016-07-12 | Warsaw Orthopedic, Inc. | Osteoimplant and method of making same |
US6638310B2 (en) | 2000-07-26 | 2003-10-28 | Osteotech, Inc. | Intervertebral spacer and implant insertion instrumentation |
US7726319B1 (en) | 2000-08-24 | 2010-06-01 | Osteotech, Inc. | Method for removal of water associated with bone while diminishing the dimensional changes associated with lyophilization |
US6761738B1 (en) | 2000-09-19 | 2004-07-13 | Sdgi Holdings, Inc. | Reinforced molded implant formed of cortical bone |
KR100811765B1 (en) * | 2000-09-19 | 2008-03-07 | 알데코아 에두아르도 아니투아 | Method for surface treatment of implants or prosthesis made of titanium or other materials |
US6432436B1 (en) * | 2000-10-03 | 2002-08-13 | Musculoskeletal Transplant Foundation | Partially demineralized cortical bone constructs |
ES2254243T3 (en) * | 2000-10-13 | 2006-06-16 | Osteotech, Inc. | OSTEOINDUCTIVE / OSTEOCONDUCTIVE COMPOSITIONS THAT MAINTAIN THE VOLUME. |
US20030120274A1 (en) * | 2000-10-20 | 2003-06-26 | Morris John W. | Implant retaining device |
EP1330216B1 (en) | 2000-10-24 | 2006-06-21 | SDGI Holdings, Inc. | Osteogenic packing device and method |
US6576249B1 (en) | 2000-11-13 | 2003-06-10 | El Gendler | Bone putty and method |
US6579319B2 (en) * | 2000-11-29 | 2003-06-17 | Medicinelodge, Inc. | Facet joint replacement |
US20050080486A1 (en) | 2000-11-29 | 2005-04-14 | Fallin T. Wade | Facet joint replacement |
AU2002245092A1 (en) * | 2000-12-08 | 2002-07-30 | Todd M. Boyce | Implant for orthopedic applications |
US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US6419703B1 (en) | 2001-03-01 | 2002-07-16 | T. Wade Fallin | Prosthesis for the replacement of a posterior element of a vertebra |
US6565605B2 (en) | 2000-12-13 | 2003-05-20 | Medicinelodge, Inc. | Multiple facet joint replacement |
US7323193B2 (en) * | 2001-12-14 | 2008-01-29 | Osteotech, Inc. | Method of making demineralized bone particles |
WO2002047732A2 (en) * | 2000-12-14 | 2002-06-20 | Osteotech, Inc. | Method of making demineralized bone particles |
US20020114795A1 (en) | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
EP1272130B1 (en) * | 2001-02-04 | 2004-11-17 | MICHELSON, Gary Karlin | Instrumentation for inserting and deploying an expandable interbody spinal fusion implant |
US6855169B2 (en) | 2001-02-28 | 2005-02-15 | Synthes (Usa) | Demineralized bone-derived implants |
US7090698B2 (en) | 2001-03-02 | 2006-08-15 | Facet Solutions | Method and apparatus for spine joint replacement |
US6749636B2 (en) * | 2001-04-02 | 2004-06-15 | Gary K. Michelson | Contoured spinal fusion implants made of bone or a bone composite material |
US6890355B2 (en) * | 2001-04-02 | 2005-05-10 | Gary K. Michelson | Artificial contoured spinal fusion implants made of a material other than bone |
US6989031B2 (en) * | 2001-04-02 | 2006-01-24 | Sdgi Holdings, Inc. | Hemi-interbody spinal implant manufactured from a major long bone ring or a bone composite |
US20070191964A1 (en) * | 2001-04-04 | 2007-08-16 | Arthrocare Corporation | Enhanced visibility materials for implantation in hard tissue |
WO2002083188A2 (en) * | 2001-04-16 | 2002-10-24 | Cassidy James J | Dense/porous structures for use as bone substitutes |
US8740987B2 (en) * | 2001-06-04 | 2014-06-03 | Warsaw Orthopedic, Inc. | Tissue-derived mesh for orthopedic regeneration |
JP2003013329A (en) * | 2001-06-26 | 2003-01-15 | Sanai Fujita | Animal bone fiber and method for producing the same |
US20050107795A1 (en) * | 2001-08-10 | 2005-05-19 | John Morris | Bone plating system and method of use |
US7371409B2 (en) | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7163691B2 (en) * | 2001-10-12 | 2007-01-16 | Osteotech, Inc. | Bone graft |
US6855167B2 (en) * | 2001-12-05 | 2005-02-15 | Osteotech, Inc. | Spinal intervertebral implant, interconnections for such implant and processes for making |
AU2002362220A1 (en) * | 2001-12-27 | 2003-07-24 | Osteotech Inc. | Bone fasteners and method for stabilizing vertebral bone facets using the bone fasteners |
US6878168B2 (en) | 2002-01-03 | 2005-04-12 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US7708776B1 (en) | 2002-01-16 | 2010-05-04 | Nuvasive, Inc. | Intervertebral disk replacement system and methods |
US20040127563A1 (en) * | 2002-03-22 | 2004-07-01 | Deslauriers Richard J. | Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
DE60333179D1 (en) * | 2002-03-29 | 2010-08-12 | Osteotech Inc | METHOD FOR PRODUCING BONE PARTICLES |
ATE490745T1 (en) | 2002-03-29 | 2010-12-15 | Wright Medical Tech Inc | BONE TRANSPLANT REPLACEMENT COMPOSITION |
EP2246012A2 (en) * | 2002-03-30 | 2010-11-03 | Infinity Orthopaedics Company, Ltd. | Intervertebral Device |
US20060204544A1 (en) * | 2002-05-20 | 2006-09-14 | Musculoskeletal Transplant Foundation | Allograft bone composition having a gelatin binder |
AU2003238805A1 (en) * | 2002-05-30 | 2003-12-19 | Osteotech, Inc. | Method and apparatus for machining a surgical implant |
US7299805B2 (en) | 2002-06-07 | 2007-11-27 | Marctec, Llc | Scaffold and method for implanting cells |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
US6652887B1 (en) | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7291179B2 (en) | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
US7744597B2 (en) | 2002-06-26 | 2010-06-29 | Lifenet Health | Device and process for producing fiber products and fiber products produced thereby |
US8771719B2 (en) | 2002-08-12 | 2014-07-08 | Warsaw Orthopedic, Inc. | Synthesis of a bone-polymer composite material |
US7270813B2 (en) * | 2002-10-08 | 2007-09-18 | Osteotech, Inc. | Coupling agents for orthopedic biomaterials |
US7582309B2 (en) * | 2002-11-15 | 2009-09-01 | Etex Corporation | Cohesive demineralized bone compositions |
US20060034881A1 (en) * | 2002-11-26 | 2006-02-16 | Eccera Co. Ltd. | Animal bone fiber and method of producing the same |
US20050251267A1 (en) * | 2004-05-04 | 2005-11-10 | John Winterbottom | Cell permeable structural implant |
US7507257B2 (en) * | 2003-02-04 | 2009-03-24 | Wright Medical Technology, Inc. | Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects |
AU2004209554B2 (en) | 2003-02-04 | 2010-08-12 | Warsaw Orthopedic, Inc. | Polyurethanes for osteoimplants |
US20050064042A1 (en) * | 2003-04-29 | 2005-03-24 | Musculoskeletal Transplant Foundation | Cartilage implant plug with fibrin glue and method for implantation |
US7067123B2 (en) * | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7494811B2 (en) | 2003-05-01 | 2009-02-24 | Lifenet Health | In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby |
US7488348B2 (en) * | 2003-05-16 | 2009-02-10 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
US7351262B2 (en) * | 2003-06-05 | 2008-04-01 | Warsaw Orthopedic, Inc. | Bone implants and methods of making same |
US7252685B2 (en) * | 2003-06-05 | 2007-08-07 | Sdgi Holdings, Inc. | Fusion implant and method of making same |
US7537617B2 (en) * | 2003-06-05 | 2009-05-26 | Warsaw Orthopedic, Inc. | Bone strip implants and method of making same |
NZ544050A (en) * | 2003-06-11 | 2009-03-31 | Osteotech Inc | Osteoimplants and methods for their manufacture |
US20050065607A1 (en) * | 2003-09-24 | 2005-03-24 | Gross Jeffrey M. | Assembled fusion implant |
US20050065613A1 (en) * | 2003-09-24 | 2005-03-24 | Gross Jeffrey M. | Reinforced fusion implant |
US20050074476A1 (en) * | 2003-10-03 | 2005-04-07 | El Gendler | Cartilidge and bone induction by artificially perforated organic bone matrix augmented by undifferentiated cells suspended in bone gel |
US7588590B2 (en) | 2003-12-10 | 2009-09-15 | Facet Solutions, Inc | Spinal facet implant with spherical implant apposition surface and bone bed and methods of use |
EP1701729B1 (en) | 2003-12-31 | 2018-05-02 | Warsaw Orthopedic, Inc. | Improved bone matrix compositions and methods |
US20070231788A1 (en) * | 2003-12-31 | 2007-10-04 | Keyvan Behnam | Method for In Vitro Assay of Demineralized Bone Matrix |
US8734525B2 (en) | 2003-12-31 | 2014-05-27 | Warsaw Orthopedic, Inc. | Osteoinductive demineralized cancellous bone |
US20120245703A1 (en) * | 2004-01-02 | 2012-09-27 | Meredith Thomas L | Composite bone material implant and method |
US8012210B2 (en) * | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
EP1708651A4 (en) | 2004-01-27 | 2011-11-02 | Osteotech Inc | Stabilized bone graft |
US20060064101A1 (en) * | 2004-02-12 | 2006-03-23 | Arthrocare Corporation | Bone access system |
US7993373B2 (en) | 2005-02-22 | 2011-08-09 | Hoy Robert W | Polyaxial orthopedic fastening apparatus |
US8562649B2 (en) | 2004-02-17 | 2013-10-22 | Gmedelaware 2 Llc | System and method for multiple level facet joint arthroplasty and fusion |
US8333789B2 (en) | 2007-01-10 | 2012-12-18 | Gmedelaware 2 Llc | Facet joint replacement |
US8900273B2 (en) * | 2005-02-22 | 2014-12-02 | Gmedelaware 2 Llc | Taper-locking fixation system |
US20050196460A1 (en) * | 2004-03-08 | 2005-09-08 | Malinin Theodore I. | Particulate cartilage compositions, processes for their preparation and methods for regenerating cartilage |
EP1789088A4 (en) | 2004-03-24 | 2009-12-30 | Doctor S Res Group Inc | Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods |
US20050244450A1 (en) * | 2004-04-28 | 2005-11-03 | Reddi A H | Heat-treated implantable bone material |
US7678385B2 (en) * | 2004-04-28 | 2010-03-16 | Biomet Manufacturing Corp. | Irradiated implantable bone material |
US8764801B2 (en) * | 2005-03-28 | 2014-07-01 | Gmedelaware 2 Llc | Facet joint implant crosslinking apparatus and method |
US7588578B2 (en) | 2004-06-02 | 2009-09-15 | Facet Solutions, Inc | Surgical measurement systems and methods |
DE102004036882A1 (en) * | 2004-07-22 | 2006-02-16 | Ossacur Ag | Bioresorbable material for filling bone defects |
DE102004036881A1 (en) * | 2004-07-22 | 2006-02-16 | Ossacur Ag | Bioresorbable material for filling bone defects |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US20060083769A1 (en) | 2004-10-14 | 2006-04-20 | Mukesh Kumar | Method and apparatus for preparing bone |
US7670384B2 (en) * | 2004-10-14 | 2010-03-02 | Biomet Manufacturing Corp. | Bone graft composition comprising a bone material and a carrier comprising denatured demineralized bone |
US7250550B2 (en) * | 2004-10-22 | 2007-07-31 | Wright Medical Technology, Inc. | Synthetic bone substitute material |
CA2594733A1 (en) * | 2005-01-14 | 2006-07-20 | Osteotech, Inc. | Expandable osteoimplant |
US20060164913A1 (en) * | 2005-01-21 | 2006-07-27 | Arthrocare Corporation | Multi-chamber integrated mixing and delivery system |
US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
US8029482B2 (en) | 2005-03-04 | 2011-10-04 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
US7947022B2 (en) | 2005-03-04 | 2011-05-24 | C. R. Bard, Inc. | Access port identification systems and methods |
WO2006096686A1 (en) | 2005-03-04 | 2006-09-14 | C.R. Bard, Inc. | Access port identification systems and methods |
US7722647B1 (en) | 2005-03-14 | 2010-05-25 | Facet Solutions, Inc. | Apparatus and method for posterior vertebral stabilization |
US7621963B2 (en) * | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
US20060233849A1 (en) * | 2005-04-13 | 2006-10-19 | Simon Bruce J | Composite bone graft material |
EP1868539A2 (en) | 2005-04-15 | 2007-12-26 | Musculoskeletal Transplant Foundation | Vertebral disc repair |
EP1896117B1 (en) | 2005-04-27 | 2011-01-12 | C.R.Bard, Inc. | Power injector system for injecting contrast media into an intravenous line |
US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
US8147455B2 (en) | 2005-04-27 | 2012-04-03 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
CN103349793B (en) | 2005-09-09 | 2016-02-10 | 阿格诺沃斯健康关爱公司 | Composite bone graft substitute cement and the goods obtained by it |
US8025903B2 (en) * | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
AU2006292224B2 (en) | 2005-09-19 | 2013-08-01 | Histogenics Corporation | Cell-support matrix and a method for preparation thereof |
US20070093900A1 (en) * | 2005-09-26 | 2007-04-26 | Williams Lytton A | Modular articulating and fusion spinal disc implant system |
AU2006308534B2 (en) * | 2005-11-01 | 2013-02-07 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
WO2007056671A1 (en) * | 2005-11-02 | 2007-05-18 | Osteotech, Inc. | Hemostatic bone graft |
EP1976459A4 (en) * | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | Porous osteoimplant |
EP1976460A4 (en) | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | Injectable and moldable bone substitute materials |
US7838022B2 (en) * | 2006-05-01 | 2010-11-23 | Warsaw Orthopedic, Inc | Malleable implants containing demineralized bone matrix |
EP2076220A2 (en) | 2006-07-25 | 2009-07-08 | Musculoskeletal Transplant Foundation | Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation |
US8043377B2 (en) * | 2006-09-02 | 2011-10-25 | Osprey Biomedical, Inc. | Implantable intervertebral fusion device |
EP2077718B2 (en) | 2006-10-27 | 2022-03-09 | Edwards Lifesciences Corporation | Biological tissue for surgical implantation |
US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US20080114465A1 (en) * | 2006-11-14 | 2008-05-15 | Zanella John M | Surface treatments of an allograft to improve binding of growth factors and cells |
US7718616B2 (en) | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
US8974496B2 (en) * | 2007-08-30 | 2015-03-10 | Jeffrey Chun Wang | Interspinous implant, tools and methods of implanting |
USD580551S1 (en) * | 2007-02-01 | 2008-11-11 | Zimmer Spine, Inc. | Spinal implant |
CA2677903A1 (en) * | 2007-02-12 | 2008-08-21 | Osteotech, Inc. | Joint revision implant |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
US9381047B2 (en) * | 2007-05-09 | 2016-07-05 | Ebi, Llc | Interspinous implant |
US20080279825A1 (en) | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
US8574825B2 (en) | 2007-06-01 | 2013-11-05 | Bacterin International, Inc. | Process for demineralization of bone matrix with preservation of natural growth factors |
US9101691B2 (en) * | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
US9554920B2 (en) | 2007-06-15 | 2017-01-31 | Warsaw Orthopedic, Inc. | Bone matrix compositions having nanoscale textured surfaces |
CA2945295C (en) * | 2007-06-15 | 2020-01-14 | Warsaw Orthopedic, Inc. | Method of treating tissue |
AU2008265850B2 (en) | 2007-06-15 | 2014-06-26 | Warsaw Orthopedic, Inc. | Bone matrix compositions and methods |
US8257325B2 (en) * | 2007-06-20 | 2012-09-04 | Medical Components, Inc. | Venous access port with molded and/or radiopaque indicia |
US20090012620A1 (en) * | 2007-07-06 | 2009-01-08 | Jim Youssef | Implantable Cervical Fusion Device |
US9492278B2 (en) * | 2007-07-10 | 2016-11-15 | Warsaw Orthopedic, Inc. | Delivery system |
US20110054408A1 (en) * | 2007-07-10 | 2011-03-03 | Guobao Wei | Delivery systems, devices, tools, and methods of use |
US20090024224A1 (en) | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
US9610432B2 (en) | 2007-07-19 | 2017-04-04 | Innovative Medical Devices, Llc | Venous access port assembly with X-ray discernable indicia |
EP2180915B1 (en) | 2007-07-19 | 2017-10-04 | Medical Components, Inc. | Venous access port assembly with x-ray discernable indicia |
US8512342B2 (en) * | 2007-08-11 | 2013-08-20 | Thomas L. Meredith | Portable bone grinder |
US9138509B2 (en) * | 2007-09-14 | 2015-09-22 | Musculoskeletal Transplant Foundation | Composition for filling bone defects |
CA2702499A1 (en) * | 2007-10-19 | 2009-04-23 | Osteotech, Inc. | Demineralized bone matrix compositions and methods |
US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
WO2009082554A2 (en) | 2007-11-09 | 2009-07-02 | Osteotech, Inc. | Bone matrix compositions having nanoscale textured surfaces |
US8961571B2 (en) * | 2007-11-19 | 2015-02-24 | David Lee | Method and apparatus for spinal facet joint fusion using irregularly shaped cortical bone implants |
US8357387B2 (en) * | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
CA2717725A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
US20090226668A1 (en) * | 2008-03-10 | 2009-09-10 | Ebi, L.P. | Optimized surface for cellular proliferation and differentiation |
WO2009120969A2 (en) * | 2008-03-28 | 2009-10-01 | Osteotech, Inc. | Bone anchors for orthopedic applications |
JP2012506733A (en) * | 2008-10-24 | 2012-03-22 | ウォーソー・オーソペディック・インコーポレーテッド | Compositions and methods for promoting bone formation |
EP2358408A2 (en) * | 2008-10-30 | 2011-08-24 | Osteotech, Inc., | Bone/polyurethane composites and methods thereof |
WO2012134540A2 (en) | 2010-10-22 | 2012-10-04 | Vanderbilt University | Injectable synthetic pur composite |
WO2010051494A1 (en) | 2008-10-31 | 2010-05-06 | C.R. Bard, Inc. | Systems and methods for identifying an acess port |
US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
WO2010093950A1 (en) | 2009-02-12 | 2010-08-19 | Osteotech, Inc. | Delivery system cartridge |
EP2451512A1 (en) | 2009-07-07 | 2012-05-16 | C.R. Bard Inc. | Extensible internal bolster for a medical device |
AU2010279618A1 (en) | 2009-08-03 | 2012-03-01 | Osteotech, Inc. | Bone matrix compositions and methods |
US20110098816A1 (en) * | 2009-10-28 | 2011-04-28 | Warsaw Orthopedic, Inc. | Sacro-iliac joint implant system and method |
JP2013510652A (en) | 2009-11-17 | 2013-03-28 | シー・アール・バード・インコーポレーテッド | Overmolded access port including locking feature and identification feature |
NZ602066A (en) | 2010-03-23 | 2013-09-27 | Edwards Lifesciences Corp | Methods of conditioning sheet bioprosthetic tissue |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8906601B2 (en) | 2010-06-17 | 2014-12-09 | Edwardss Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
EP2608778B1 (en) | 2010-08-26 | 2017-11-01 | University of Louisville Research Foundation, Inc. | Compositions and methods for treating bone defects |
CN103313733A (en) | 2010-11-15 | 2013-09-18 | 捷迈整形外科生物材料有限公司 | Bone void fillers |
US9351829B2 (en) | 2010-11-17 | 2016-05-31 | Edwards Lifesciences Corporation | Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability |
USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
US8920511B2 (en) | 2011-11-17 | 2014-12-30 | Allosource | Multi-piece machine graft systems and methods |
US9162011B2 (en) | 2011-12-19 | 2015-10-20 | Allosource | Flowable matrix compositions and methods |
US9585764B2 (en) * | 2012-07-26 | 2017-03-07 | Warsaw Orthopedic, Inc. | Bone implant device |
US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
US9265609B2 (en) * | 2013-01-08 | 2016-02-23 | Warsaw Orthopedic, Inc. | Osteograft implant |
AU2014218734B2 (en) | 2013-02-22 | 2018-03-15 | Allosource | Cartilage mosaic compositions and methods |
AU2014225458A1 (en) | 2013-03-07 | 2015-07-09 | Allosource | Consistent calcium content bone allograft systems and methods |
EP2970882B1 (en) | 2013-03-15 | 2018-11-28 | AlloSource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
WO2014151939A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Perforated osteochondral allograft compositions |
US9572912B2 (en) | 2013-04-19 | 2017-02-21 | Theracell, Inc. | Demineralized bone fibers having controlled geometry and shapes and methods thereof |
CN103357112B (en) * | 2013-07-05 | 2015-02-18 | 西安邮电大学 | Quantum entanglement teleportation-based spinal cord injury nerve signal relay system and method |
US9861724B2 (en) * | 2013-08-06 | 2018-01-09 | Fusion Innovations, Llc | Method for fusion of fractured or voided sternum post sternotomy |
CA2926421C (en) | 2013-10-08 | 2022-05-03 | Vivorte, Inc. | Processed bone particle compositions and related methods |
US10173375B2 (en) | 2014-03-05 | 2019-01-08 | Bacterin International, Inc. | Shaped fiber-based products and method of manufacture thereof |
US9730796B2 (en) | 2014-05-16 | 2017-08-15 | Allosource | Composite bone constructs and methods |
AU2015346100B2 (en) | 2014-11-14 | 2018-10-18 | Warsaw Orthopedic, Inc. | Bone graft materials, devices and methods of use |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
EP3297694A1 (en) | 2015-05-21 | 2018-03-28 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
US10821004B2 (en) * | 2015-06-30 | 2020-11-03 | Bacterin Interational, Inc. | Expandable bone grafts and methods of manufacture thereof |
US10549011B2 (en) | 2015-10-26 | 2020-02-04 | Osteolife Biomedical, Llc | Bone putty and gel systems and methods |
US20170128633A1 (en) | 2015-11-10 | 2017-05-11 | Theodore Malinin | Bioactive Implants and Methods of Making and Using |
USD849946S1 (en) | 2015-12-30 | 2019-05-28 | Nuvasive, Inc. | Interspinous process spacer |
US11090411B2 (en) | 2016-01-28 | 2021-08-17 | Warsaw Orthopedic, Inc. | Electron beam irradiated osteoinductive bone implant |
WO2017218545A1 (en) * | 2016-06-13 | 2017-12-21 | Lifenet Health | Demineralized bone fibers and preparation thereof |
US10813763B2 (en) | 2016-07-26 | 2020-10-27 | Warsaw Orthopedic, Inc. | Implantable mesh |
WO2021050566A1 (en) | 2019-09-11 | 2021-03-18 | Warsaw Orthopedic, Inc. | Hydratable bone material and methods of use |
US11927393B2 (en) * | 2020-04-30 | 2024-03-12 | Dci Donor Services, Inc. | Fiber slurry tray and process |
US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3739773A (en) * | 1963-10-31 | 1973-06-19 | American Cyanamid Co | Polyglycolic acid prosthetic devices |
US4430760A (en) * | 1981-12-18 | 1984-02-14 | Collagen Corporation | Nonstress-bearing implantable bone prosthesis |
US4472840A (en) * | 1981-09-21 | 1984-09-25 | Jefferies Steven R | Method of inducing osseous formation by implanting bone graft material |
US4440750A (en) * | 1982-02-12 | 1984-04-03 | Collagen Corporation | Osteogenic composition and method |
US4932973A (en) * | 1983-09-30 | 1990-06-12 | El Gendler | Cartilage and bone induction by artificially perforated organic bone matrix |
US5053049A (en) * | 1985-05-29 | 1991-10-01 | Baxter International | Flexible prostheses of predetermined shapes and process for making same |
US4627853A (en) * | 1985-05-29 | 1986-12-09 | American Hospital Supply Corporation | Method of producing prostheses for replacement of articular cartilage and prostheses so produced |
US5061286A (en) * | 1989-08-18 | 1991-10-29 | Osteotech, Inc. | Osteoprosthetic implant |
US5290558A (en) * | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5073373A (en) * | 1989-09-21 | 1991-12-17 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5236456A (en) * | 1989-11-09 | 1993-08-17 | Osteotech, Inc. | Osteogenic composition and implant containing same |
US5112354A (en) * | 1989-11-16 | 1992-05-12 | Northwestern University | Bone allograft material and method |
DE69111021T2 (en) * | 1990-10-31 | 1996-01-04 | Gendler El | Flexible membrane made from organic bone matrix for repairing and restoring bones. |
US5092887A (en) * | 1991-08-12 | 1992-03-03 | El Gendler | Artificial ligament produced from demineralized bone for the replacement and augmentation of ligaments, tendons and other fibrous connective tissue |
US5314476A (en) * | 1992-02-04 | 1994-05-24 | Osteotech, Inc. | Demineralized bone particles and flowable osteogenic composition containing same |
EP0555807B1 (en) * | 1992-02-10 | 1996-08-21 | Matsumoto Dental College | Bone substitute product and method of producing the same |
-
1993
- 1993-12-09 US US08/164,152 patent/US5507813A/en not_active Expired - Lifetime
-
1994
- 1994-12-08 ES ES95904299T patent/ES2173946T3/en not_active Expired - Lifetime
- 1994-12-08 AT AT95904299T patent/ATE213958T1/en not_active IP Right Cessation
- 1994-12-08 EP EP95904299A patent/EP0732947B1/en not_active Expired - Lifetime
- 1994-12-08 WO PCT/US1994/014138 patent/WO1995015776A1/en active IP Right Grant
- 1994-12-08 JP JP51635495A patent/JP3471359B2/en not_active Expired - Fee Related
- 1994-12-08 CA CA002177017A patent/CA2177017C/en not_active Expired - Lifetime
- 1994-12-08 DE DE69430069T patent/DE69430069T2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
Also Published As
Publication number | Publication date |
---|---|
ATE213958T1 (en) | 2002-03-15 |
ES2173946T3 (en) | 2002-11-01 |
DE69430069D1 (en) | 2002-04-11 |
JPH09506281A (en) | 1997-06-24 |
EP0732947B1 (en) | 2002-03-06 |
DE69430069T2 (en) | 2002-10-10 |
EP0732947A1 (en) | 1996-09-25 |
WO1995015776A1 (en) | 1995-06-15 |
CA2177017A1 (en) | 1995-06-15 |
JP3471359B2 (en) | 2003-12-02 |
US5507813A (en) | 1996-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2177017C (en) | Shaped materials derived from elongate bone particles and process for making same | |
EP0880345B1 (en) | Process for producing flexible sheets from demineralized, elongate, bone particles | |
EP1140239B1 (en) | Bone graft made of bone particles | |
US9393116B2 (en) | Osteoimplants and methods for their manufacture | |
CA2363153C (en) | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same | |
EP1301222B1 (en) | Osteoimplant and method of making same | |
CA2415061C (en) | Osteogenic implants derived from bone | |
AU2001275999A1 (en) | Osteoimplant and method of making same | |
AU2001270153A1 (en) | Osteogenic implants derived from bone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20141208 |